Press Releases
March 15, 2023
HOOKIPA Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook
March 13, 2023
HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors
March 8, 2023
HOOKIPA Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide a Corporate Update on March 15, 2023
February 13, 2023
HOOKIPA Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers
February 7, 2023
HOOKIPA to Present at the SVB Securities Global Biopharma Conference
January 4, 2023
HOOKIPA Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine